Weitz & Luxenberg is taking cases of seizures, hemorrhagic strokes (intracerebral hemorrhage), and bronchiolitis obliterans organizing pneumonia (BOOP), also known as cryptogenic organizing pneumonia or COP, among teens and young adults following a U.S. Food and Drug Administration (FDA) announcement that noted several voluntary adverse event reports of individuals, especially youth and young adults, who have experienced seizures after vaping with e-cigarettes.

“The tobacco industry has made questionable claims that e-cigarettes are a ‘safe’ alternative to combustible tobacco products,” said Ellen Relkin, Weitz & Luxenberg’s practice group co-chair for defective drugs and medical devices. “What is clear is that these electronic cigarettes likely have their own unique health and safety dangers, in addition to those accompanying any tobacco use, which is particularly troubling given manufacturers’ aggressive marketing to teenagers and young adults, and the subsequent increase in use among these populations.”

Risks from E-Cigarettes

In its official statement, the FDA noted it was concerned regarding the potential link between e-cigarettes and seizures noted in adverse event reports it had received. The FDA noted that seizures were reported by both first-time and frequent e-cigarette users. Other studies have linked e-cigarettes with increased arterial stiffness and blood pressure, which lends additional significant concern for the potential for e-cigarette users to have increased risk of hemorrhagic strokes.

In addition, there is medical literature that provides evidence that e-cigarettes can also lead to pulmonary toxicity and tissue damage, which may manifest as bronchiolitis obliterans organizing pneumonia (BOOP) or cryptogenic organizing pneumonia (COP), a type of lung condition characterized by inflammation and stiffening of areas of the lungs.

W&L Can Help E-Cigarette Users Who Have Suffered Seizures, Hemorrhagic Strokes, or Bronchiolitis Obliterans Organizing Pneumonia

Weitz & Luxenberg encourages youth or young adults under the age of 25 who have experienced seizures, bronchiolitis obliterans organizing pneumonia, or hemorrhagic stroke after using e-cigarettes to contact the firm using the online form on this page or by calling (855) 274-5624 for a free consultation.

Contact Weitz & Luxenberg if:

  • You or a loved one who is under the age of 25 have experienced the following injuries after using blu, JUUL, Logic, MarkTen, or Vuse branded e-cigarettes:
    • Seizure requiring overnight hospitalization.
    • Seizure resulting in trauma or recurrent seizures.
    • Bronchiolitis obliterans organizing pneumonia or cryptogenic organizing pneumonia requiring hospitalization for multiple days.
    • Hemorrhagic stroke (intracerebral hemorrhage), including subarachnoid hemorrhage, intraparenchymal hemorrhage, or intraventricular hemorrhage.
    • Death due to any of the above.

W&L’s Drug and Medical Device Litigation practice group has won more than $12 billion in verdicts and settlements for clients in drug and medical device litigations, and our experienced attorneys can help explain and explore all of your legal options.*

*Past performance is no guarantee of future results. The settlements in which Weitz & Luxenberg played leadership roles included patients not represented by W&L.

Get the Help You Need Today

Free Case Review